Regional leadership The Christie NHS Foundation Trust is a leading cancer centre serving 3.2 million people from Manchester and beyond, with a large patient base and high-volume treatment operations. This suggests strong potential for enterprise partnerships in large-scale procurement, patient support services, and international collaborations.

Large treatment footprint With one of the world’s largest radiotherapy departments, onsite chemotherapy, and complex surgical capabilities, there are opportunities to offer integrated medical devices, software, and service contracts that streamline radiotherapy planning, chemotherapy logistics, and surgical support workflows.

Research & trials Active involvement in over 650 cancer trials positions the Trust as a potential partner for clinical trial technology, data management, patient recruitment platforms, and partnerships with CROs or biotech firms seeking NHS-based trial sites and real-world evidence.

Digital & interoperability Existing tech stack and EPR integration indicate openness to digital health enhancements, including EPR extensions, interoperability tools, patient engagement platforms, and cloud-based analytics to improve outcomes and operational efficiency.

Fundraising & partnerships Active Christie International collaborations and charity-driven fundraising activity show appetite for philanthropic partnerships, sponsorships, and donor-driven health initiatives that can align with corporate social responsibility programs and patient support services.